Kurrle E - Search Results

1

[Intensive combined therapy for high-risk ALL patients].

Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, Kurrle E, Heimpel H, Koch P, Lipp T, et al. Hoelzer D, et al. Among authors: kurrle e. Onkologie. 1988 Feb;11(1):18-24. doi: 10.1159/000216474. Onkologie. 1988. PMID: 3283621 Clinical Trial. German.

2

[Induction and intensive combined therapy of acute myeloid leukemia in adults].

Kurrle E, Ehninger G, Freund M, Heil G, Hoelzer D, Link H, Mitrou PS, Ohl S, Queisser W, Schlimok G, et al. Kurrle E, et al. Onkologie. 1988 Feb;11(1):5-9. doi: 10.1159/000216470. Onkologie. 1988. PMID: 3283626 German.

3

TAD-induction therapy for 175 adults with acute myeloid leukemia, followed by consolidation and maintenance therapy. The joint study of Ulm and Tübingen.

Link H, Kurrle E, Frauer HM, Heil G, Heimpel H, Waller HD, Ostendorf P, Wilms K, Hoelzer D. Link H, et al. Among authors: kurrle e. Onkologie. 1986 Jun;9(3):135-8. doi: 10.1159/000215985. Onkologie. 1986. PMID: 3528958

4

Age adapted induction and intensified consolidation therapy in acute myelogenous leukemia.

Kurrle E, Ehninger G, Freund M, Heil G, Hoelzer D, Link H, Mitrou PS. Kurrle E, et al. Onkologie. 1986 Jun;9(3):141-3. doi: 10.1159/000215987. Onkologie. 1986. PMID: 3528959

5

[Effectiveness of gnotobiotic measures in the treatment of acute leukemia: the results of a prospective randomized clinical study].

Dietrich M, Abt C, Arnold R, Pflieger H, Hoelzer D, Kurrle E, Rasche H, Kubanek B, Heimpel H, Fliedner TM. Dietrich M, et al. Among authors: kurrle e. Onkologie. 1979 Jun;2(3):102-7. doi: 10.1159/000214484. Onkologie. 1979. PMID: 392375 Clinical Trial. German.

6

Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.

Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, Kurrle E, Heimpel H, Koch P, Lipp T, et al. Hoelzer D, et al. Among authors: kurrle e. Semin Oncol. 1987 Jun;14(2 Suppl 1):92-7. Semin Oncol. 1987. PMID: 3473688 No abstract available.

7

[High-dose cytosine arabinoside in the treatment of recurrent or acute refractory myeloid leukemias].

Brudler O, Heil G, Kurrle E. Brudler O, et al. Among authors: kurrle e. Onkologie. 1985 Feb;8(1):39-40, 42-3. doi: 10.1159/000215609. Onkologie. 1985. PMID: 3885119 German.

8

[Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982].

Kurrle E, Hoelzer D, Heimpel H. Kurrle E, et al. Folia Haematol Int Mag Klin Morphol Blutforsch. 1985;112(5):698-709. Folia Haematol Int Mag Klin Morphol Blutforsch. 1985. PMID: 2416646 German.

9

A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia.

Kurrle E, Ehninger G, Freund M, Heil G, Hoelzer D, Link H, Mitrou PS, Ohl S, Queisser W, Schlimok G, et al. Kurrle E, et al. Blut. 1988 May;56(5):233-6. doi: 10.1007/BF00320111. Blut. 1988. PMID: 3285914 Clinical Trial. No abstract available.

10

Ultrastructural demonstration of peroxidase expression in acute unclassified leukemias: correlation to immunophenotype and treatment outcome.

Heil G, Gunsilius E, Raghavachar A, Bartram CR, Ganser A, Kurrle E, Aydemir U, Löffler H, Hoelzer D, Thiel E, et al. Heil G, et al. Among authors: kurrle e. Blood. 1991 Mar 15;77(6):1305-12. Blood. 1991. PMID: 1848115 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters